NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE3769.40-36.3 (-0.95 %)
PREV CLOSE ( ) 3805.70
OPEN PRICE ( ) 3868.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1209
TODAY'S LOW / HIGH ( )3750.00 3868.95
52 WK LOW / HIGH ( )1262.55 4338
NSE3782.15-29.15 (-0.76 %)
PREV CLOSE( ) 3811.30
OPEN PRICE ( ) 3830.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3782.15 (87)
VOLUME 25361
TODAY'S LOW / HIGH( ) 3749.65 3850.00
52 WK LOW / HIGH ( )1260.75 4340
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.